AbbVie, the global biopharmaceutical research-focused company, just opened its R&D facilities to tour for the first time, including the AbbVie Cambridge Research Center and the Worcester Bioresearch Center, situated in Boston, USA. The event proved to be a great way to show off the innovation of the company's strategies in drug discovery and development. Its participants walked through the various therapeutic areas that AbbVie possessed and learned about the most advanced stages of clinical research and discovery initiatives.
The CRISP (Clinical Research Advancement Integrated Signature Program) will support advancing clinical research capabilities in the region, matching the mutual interests of the participating countries in advancing research and becoming a regional hub of studies, leading to improved standards of care for patients.
The visit was attended by a group of healthcare leaders, scientists, and other experts from several countries in the region, specifically from Algeria, Saudi Arabia, and the UAE. The attendees were introduced to the advanced technologies and processes driving new treatments as experts in these research centers work tirelessly to innovate, experiment, and push the boundaries of medical science.
Experts also participated in valuable discussions focused on the science, technology, and pioneering research in oncology, immunology, and neuroscience that drive the company forward in its mission to discover and deliver innovative medicines and solutions that solve serious health issues today, address the medical challenges of tomorrow, and improve patients’ lives.
Mohammad Aboubakr, Regional Vice President for the Middle East, Africa, and Russia said: “The CRISP (Clinical Research Advancement Integrated Signature Program) program is designed to equip its partners with the knowledge and skills needed to excel and advance clinical research in their regions and countries.The project consists of two parts: the Research and Development Site Experience and the CRISP Academy. Furthermore, the CRISP Academy, in partnership with ACRP (Association of Clinical Research Professionals), was highlighted, emphasizing the shared commitment to boosting research capabilities and fostering collaboration across the region.”
Regional Medical Director for the MEAR region at AbbVie, Yasser Nour, said CRISP is indeed an 'umbrella' of any scientific program conducted by AbbVie, which truly underscores its commitment to evidence development. The program has further strengthened AbbVie's scientific vision in the Middle East, Africa, and Russia towards ultimately bettering patient outcomes. Nour announced a clinical research academy in the pipeline, aimed at enhancing research capabilities by focusing on fundamental principles as well as key topics in the field of research.
